Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

COBRA PzF™ Coronary Stent in Clinical and Preclinical Studies: Setting the Stage for New Antithrombotic strategies?

Future Cardiology(2021)10.2217/fca-2021-0057Source: DataRank Database

COBRA PzF™ Coronary Stent in Clinical and Preclinical Studies: Setting the Stage for New Antithrombotic strategies? is a research paper published in Future Cardiology (2021). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (112 grants)Impact (FWCI 1.82)OA: hybridTopics (47)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Atsushi Sakamoto ORCID,Yu Sato ORCID,Rika Kawakami ORCID,Masayuki Mori ORCID,Kenji Kawai ORCID

Live enrichment

PubMed:34521223 PMC:PMC8977992 OpenAlex:https://openalex.org/W3200552729

Leducq Foundation

Grant: R01 HL141425

National Institutes of Health

Grant: HL141425

National Institutes of Health

Grant: 5R01HL141425-04

IL1beta signaling in SMCpromotes beneficial changes in late stage atherosclerotic lesion pathogenesis

Amgen

Boston Scientific Corporation

Celonova

Lifetech

MedAlliance

Microport Medical

Recor

W.L. Gore

4C Medical

Cook Medical

Edwards Lifesciences

Mitra assist

NAMSA

NIPRO

Neovasc

Protembis

Qool

Senseonics

SinoMed

Vesper

Xeltis

4Tech

Mercator

Novogate

Orbus Neich

Surmodics

480 Biomedical

Biomedical

DuNing, Inc

Endotronix

Symic

Cardiac Implants

Envision Scientific

Lutonix/Bard

Medtronic

Occlutech

AWS COVID-19 Diagnostic Development Initiative

Claret Medical

Concept Medical

Limflo

Mitraalign

Phenox

Spectranetics

Accumedical

Biosensors International Group

Emboline

Nanova

Profusa

Shockwave

Abbott Vascular

CSI

Gateway

Merill

Microvention

Terumo BCT

Lutonix/Bard

Accumedical

Novogate

Mitraalign

Recor

Biosensors International Group

Boston Scientific Corporation

Phenox

Concept Medical

W.L. Gore

Cook Medical

Surmodics

MedAlliance

NAMSA

Lifetech

Symic

Gateway

DuNing, Inc

Limflo

Vesper

Microvention

Celonova

Medtronic

Qool

Emboline

SinoMed

Neovasc

Amgen

Occlutech

Merill

Protembis

Edwards Lifesciences

CSI

480 Biomedical

Shockwave

4C Medical

Nanova

Terumo BCT

Orbus Neich

AWS COVID-19 Diagnostic Development Initiative

Spectranetics

Claret Medical

Microport Medical

Endotronix

Cardiac Implants

Profusa

Envision Scientific

NIPRO

Mitra assist

Mercator

Xeltis

Senseonics

Abbott Vascular

4Tech

FWCI

1.82

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.2217/fca-2021-0057

publisherhttps://doi.org/10.2217/fca-2021-0057

publisherhttps://www.tandfonline.com/doi/pdf/10.2217/fca-2021-0057

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34521223

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8977992

Fields of Study

Coronary Interventions and DiagnosticsAntiplatelet Therapy and Cardiovascular DiseasesCardiac Imaging and Diagnostics03 medical and health sciences0302 clinical medicineCoated Materials, BiocompatibleCoronary RestenosisDrug-Eluting StentsFibrinolytic AgentsHumansProsthesis DesignStentsTreatment Outcome

MeSH Terms

Fibrinolytic AgentsHumansProsthesis DesignStentsTreatment OutcomeCoated Materials, BiocompatibleCoronary RestenosisDrug-Eluting Stents

Keywords

MedicineAntithromboticCobraStage (stratigraphy)CardiologyInternal medicinePercutaneous coronary interventionCoronary stentStentIntensive care medicineRestenosisMyocardial infarctionHealingOral AnticoagulationHigh Bleeding RiskCobra Pzf StentPolyzene FCoronary RestenosisTreatment OutcomeCoated Materials, BiocompatibleFibrinolytic AgentsHumansDrug-Eluting StentsStentsReviewProsthesis Design

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

COBRA PzF™ Coronary Stent in Clinical and Preclinical Studies: Setting the Stage for New Antithrombotic strategies?

FAIR Checklist

Authors (12)

Funding (112 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)